Title: Absence of pharmacokinetic interaction between intravenous peramivir and oral oseltamivir or rimantadine in humans.
Journal: Journal of clinical pharmacology 20120901
Title: Recent advances in neuraminidase inhibitor development as anti-influenza drugs.
Journal: ChemMedChem 20120901
Title: Efficacy of a single intravenous dose of the neuraminidase inhibitor peramivir in the treatment of equine influenza.
Journal: Veterinary journal (London, England : 1997) 20120801
Title: In vitro neuraminidase inhibitory activities of four neuraminidase inhibitors against influenza viruses isolated in the 2010-2011 season in Japan.
Journal: Journal of infection and chemotherapy : official journal of the Japan Society of Chemotherapy 20120801
Title: In vitro passaging of a pandemic H1N1/09 virus selects for viruses with neuraminidase mutations conferring high-level resistance to oseltamivir and peramivir, but not to zanamivir.
Journal: The Journal of antimicrobial chemotherapy 20120801
Title: Editorial commentary: What did we learn from the emergency use authorization of peramivir in 2009?
Journal: Clinical infectious diseases : an official publication of the Infectious Diseases Society of America 20120701
Title: Emergency use authorization for intravenous peramivir: evaluation of safety in the treatment of hospitalized patients infected with 2009 H1N1 influenza A virus.
Journal: Clinical infectious diseases : an official publication of the Infectious Diseases Society of America 20120701
Title: Peramivir use for treatment of hospitalized patients with influenza A(H1N1)pdm09 under emergency use authorization, October 2009-June 2010.
Journal: Clinical infectious diseases : an official publication of the Infectious Diseases Society of America 20120701
Title: Neuropathology of H5N1 virus infection in ferrets.
Journal: Veterinary microbiology 20120504
Title: Combinations of favipiravir and peramivir for the treatment of pandemic influenza A/California/04/2009 (H1N1) virus infections in mice.
Journal: Antiviral research 20120401
Title: Peramivir for the treatment of influenza.
Journal: Expert review of anti-infective therapy 20120201
Title: Use of intravenous peramivir for treatment of severe influenza A(H1N1)pdm09.
Journal: PloS one 20120101
Title: Drugs: Lines of defence.
Journal: Nature 20111207
Title: The de-guanidinylated derivative of peramivir remains a potent inhibitor of influenza neuraminidase.
Journal: Bioorganic & medicinal chemistry letters 20111201
Title: Pharmacokinetic assessment of peramivir in a hospitalized adult undergoing continuous venovenous hemofiltration.
Journal: The Annals of pharmacotherapy 20111201
Title: [Clinical efficiency in children treated with intravenous drip infusion of peramivir].
Journal: The Japanese journal of antibiotics 20111201
Title: Influenza B viruses with mutation in the neuraminidase active site, North Carolina, USA, 2010-11.
Journal: Emerging infectious diseases 20111101
Title: Characterization of the binding affinities of peramivir and oseltamivir carboxylate to the neuraminidase enzyme.
Journal: Antiviral research 20110901
Title: Postpartum pharmacokinetics of peramivir in the treatment of 2009 H1N1 influenza.
Journal: Obstetrics and gynecology 20110801
Title: Use of intravenous neuraminidase inhibitors during the 2009 pandemic: results from population-based surveillance.
Journal: JAMA 20110713
Title: A single intramuscular injection of neuraminidase inhibitor peramivir demonstrates antiviral activity against novel pandemic A/California/04/2009 (H1N1) influenza virus infection in mice.
Journal: Antiviral research 20110401
Title: Clinical experience in adults and children treated with intravenous peramivir for 2009 influenza A (H1N1) under an Emergency IND program in the United States.
Journal: Clinical infectious diseases : an official publication of the Infectious Diseases Society of America 20110315
Title: Peramivir: another tool for influenza treatment?
Journal: Clinical infectious diseases : an official publication of the Infectious Diseases Society of America 20110315
Title: Successful salvage therapy with inhaled zanamivir in a patient with peramivir-resistant pandemic influenza A (H1N1) 2009 virus.
Journal: Scandinavian journal of infectious diseases 20110201
Title: The emergency use authorization of peramivir IV: a view from the manufacturer.
Journal: Clinical pharmacology and therapeutics 20110201
Title: Generation and characterization of recombinant pandemic influenza A(H1N1) viruses resistant to neuraminidase inhibitors.
Journal: The Journal of infectious diseases 20110101
Title: Economic model for emergency use authorization of intravenous peramivir.
Journal: The American journal of managed care 20110101
Title: Real time enzyme inhibition assays provide insights into differences in binding of neuraminidase inhibitors to wild type and mutant influenza viruses.
Journal: PloS one 20110101
Title: Synergistic effects in the designs of neuraminidase ligands: analysis from docking and molecular dynamics studies.
Journal: Journal of theoretical biology 20101207
Title: Combination of peramivir and rimantadine demonstrate synergistic antiviral effects in sub-lethal influenza A (H3N2) virus mouse model.
Journal: Antiviral research 20101201
Title: Early emergence of an H275Y mutation in a hematopoietic cell transplant recipient treated with intravenous peramivir.
Journal: Transplant infectious disease : an official journal of the Transplantation Society 20101201
Title: A fourth scale sensitive to the magnetic field; intermolecular frequency symmetry in a specific interaction between protein and low-molecular compound.
Journal: Chemical & pharmaceutical bulletin 20101201
Title: The role of clinical pharmacology in supporting the emergency use authorization of an unapproved anti-influenza drug, peramivir.
Journal: Clinical pharmacology and therapeutics 20101101
Title: Peramivir for severe influenza infection in a patient with diabetic nephropathy.
Journal: American journal of respiratory and critical care medicine 20101101
Title: Combinations of oseltamivir and peramivir for the treatment of influenza A (H1N1) virus infections in cell culture and in mice.
Journal: Antiviral research 20101001
Title: Peramivir pharmacokinetics in two critically ill adults with 2009 H1N1 influenza A concurrently receiving continuous renal replacement therapy.
Journal: Pharmacotherapy 20101001
Title: Structural and functional basis of resistance to neuraminidase inhibitors of influenza B viruses.
Journal: Journal of medicinal chemistry 20100909
Title: [Current anti-influenza virus chemotherapy].
Journal: Nihon rinsho. Japanese journal of clinical medicine 20100901
Title: Treatment options for H5N1: lessons learned from the H1N1 pandemic.
Journal: Postgraduate medicine 20100901
Title: Peramivir clearance in continuous renal replacement therapy.
Journal: Hemodialysis international. International Symposium on Home Hemodialysis 20100701
Title: Targeting pandemic influenza: a primer on influenza antivirals and drug resistance.
Journal: The Journal of antimicrobial chemotherapy 20100601
Title: Peramivir and its use in H1N1 influenza.
Journal: Drugs of today (Barcelona, Spain : 1998) 20100601
Title: Respiratory failure caused by 2009 novel influenza A/H1N1 in a hematopoietic stem-cell transplant recipient: Detection of extrapulmonary H1N1 RNA and use of intravenous peramivir.
Journal: Annals of internal medicine 20100504
Title: Rapid selection of oseltamivir- and peramivir-resistant pandemic H1N1 virus during therapy in 2 immunocompromised hosts.
Journal: Clinical infectious diseases : an official publication of the Infectious Diseases Society of America 20100501
Title: Losing the opportunity to study influenza drugs.
Journal: JAMA 20100303
Title: [Research progress of anti-influenza virus agents].
Journal: Yao xue xue bao = Acta pharmaceutica Sinica 20100301
Title: Host cell selection of influenza neuraminidase variants: implications for drug resistance monitoring in A(H1N1) viruses.
Journal: Antiviral research 20100201
Title: [Emergency admission of peramivir in the U.S.A].
Journal: Pharmazie in unserer Zeit 20100101
Title: Intravenous peramivir emergency use authorization 2009: update for the clinical nurse specialist.
Journal: Clinical nurse specialist CNS 20100101
Title: Peramivir: an intravenous neuraminidase inhibitor for the treatment of 2009 H1N1 influenza.
Journal: The Annals of pharmacotherapy 20100101
Title: Pandemic (H1N1) 2009-associated ARDS rescued by neuraminidase inhibitors with emergency use of extracorporeal membrane oxygenation.
Journal: Internal medicine (Tokyo, Japan) 20100101
Title: Fulminant fatal swine influenza (H1N1): Myocarditis, myocardial infarction, or severe influenza pneumonia?
Journal: Heart & lung : the journal of critical care 20100101
Title: Comprehensive assessment of 2009 pandemic influenza A (H1N1) virus drug susceptibility in vitro.
Journal: Antiviral therapy 20100101
Title: Successful management of fulminant influenza A subtype H1N1 myocarditis.
Journal: BMJ case reports 20100101
Title: Emergency-use authorization of peramivir.
Journal: American journal of health-system pharmacy : AJHP : official journal of the American Society of Health-System Pharmacists 20091215
Title: The Emergency Use Authorization of peramivir for treatment of 2009 H1N1 influenza.
Journal: The New England journal of medicine 20091203
Title: Dynamic behavior of avian influenza A virus neuraminidase subtype H5N1 in complex with oseltamivir, zanamivir, peramivir, and their phosphonate analogues.
Journal: Journal of chemical information and modeling 20091001
Title: Emergence and spread of oseltamivir-resistant A(H1N1) influenza viruses in Oceania, South East Asia and South Africa.
Journal: Antiviral research 20090701
Title: Quantification of peramivir (a novel anti-influenza drug) in human plasma by hydrophilic interaction chromatography/tandem mass spectrometry.
Journal: Journal of chromatography. B, Analytical technologies in the biomedical and life sciences 20090401
Title: Developing new antiviral agents for influenza treatment: what does the future hold?
Journal: Clinical infectious diseases : an official publication of the Infectious Diseases Society of America 20090101
Title: Development and validation of a high-throughput zwitterionic hydrophilic interaction liquid chromatography solid-phase extraction-liquid chromatography-tandem mass spectrometry method for determination of the anti-influenza drug peramivir in plasma.
Journal: Journal of chromatography. A 20081226
Title: Intramuscularly administered neuraminidase inhibitor peramivir is effective against lethal H5N1 influenza virus in mice.
Journal: Antiviral research 20081101
Title: Understanding of known drug-target interactions in the catalytic pocket of neuraminidase subtype N1.
Journal: Proteins 20080601
Title: Injectable peramivir mitigates disease and promotes survival in ferrets and mice infected with the highly virulent influenza virus, A/Vietnam/1203/04 (H5N1).
Journal: Virology 20080425
Title: Neuraminidase inhibitor resistance in influenza viruses.
Journal: Journal of medical virology 20071001
Title: Characterization of drug-resistant recombinant influenza A/H1N1 viruses selected in vitro with peramivir and zanamivir.
Journal: Antiviral research 20070501
Title: Susceptibility of highly pathogenic A(H5N1) avian influenza viruses to the neuraminidase inhibitors and adamantanes.
Journal: Antiviral research 20070301
Title: Characterization of multidrug-resistant influenza A/H3N2 viruses shed during 1 year by an immunocompromised child.
Journal: Clinical infectious diseases : an official publication of the Infectious Diseases Society of America 20061215
Title: [Peramivir. A new and potent neuraminidase inhibitor for the treatment of influenza].
Journal: Revista espanola de quimioterapia : publicacion oficial de la Sociedad Espanola de Quimioterapia 20061201
Title: Evaluation of methyl inosine monophosphate (MIMP) and peramivir activities in a murine model of lethal influenza A virus infection.
Journal: Antiviral research 20060801
Title: Anti-influenza virus activity of peramivir in mice with single intramuscular injection.
Journal: Antiviral research 20060101
Title: Impact of neuraminidase mutations conferring influenza resistance to neuraminidase inhibitors in the N1 and N2 genetic backgrounds.
Journal: Antiviral therapy 20060101
Title: Comparison of the anti-influenza virus activity of cyclopentane derivatives with oseltamivir and zanamivir in vivo.
Journal: Bioorganic & medicinal chemistry 20050602
Title: Efficacy and tolerability of the oral neuraminidase inhibitor peramivir in experimental human influenza: randomized, controlled trials for prophylaxis and treatment.
Journal: Antiviral therapy 20050101
Title: A reverse genetics study of resistance to neuraminidase inhibitors in an influenza A/H1N1 virus.
Journal: Antiviral therapy 20040801
Title: Identification of a human influenza type B strain with reduced sensitivity to neuraminidase inhibitor drugs.
Journal: Virus research 20040701
Title: Inhibition of influenza virus infections in immunosuppressed mice with orally administered peramivir (BCX-1812).
Journal: Antiviral research 20030901
Title: Stereoselective total synthesis of racemic BCX-1812 (RWJ-270201) for the development of neuraminidase inhibitors as anti-influenza agents.
Journal: The Journal of organic chemistry 20030822
Title: A point mutation in influenza B neuraminidase confers resistance to peramivir and loss of slow binding.
Journal: Antiviral research 20030601
Title: Population analysis of the pharmacokinetics and pharmacodynamics of RWJ-270201 (BCX-1812) in treating experimental influenza A and B virus in healthy volunteers.
Journal: AAPS pharmSci 20021201
Title: A release-competent influenza A virus mutant lacking the coding capacity for the neuraminidase active site.
Journal: The Journal of general virology 20021101
Title: Peramivir (BCX-1812, RWJ-270201): potential new therapy for influenza.
Journal: Expert opinion on investigational drugs 20020601
Title: Susceptibility of recent Canadian influenza A and B virus isolates to different neuraminidase inhibitors.
Journal: Antiviral research 20020601
Title: Structural studies of the resistance of influenza virus neuramindase to inhibitors.
Journal: Journal of medicinal chemistry 20020523
Title: Combination treatment of influenza A virus infections in cell culture and in mice with the cyclopentane neuraminidase inhibitor RWJ-270201 and ribavirin.
Journal: Chemotherapy 20020501
Title: Accumulation of defective neuraminidase (NA) genes by influenza A viruses in the presence of NA inhibitors as a marker of reduced dependence on NA.
Journal: The Journal of infectious diseases 20020301
Title: Detection of influenza virus resistance to neuraminidase inhibitors by an enzyme inhibition assay.
Journal: Antiviral research 20020101
Title: RWJ-270201 (BCX-1812): a novel neuraminidase inhibitor for influenza.
Journal: Philosophical transactions of the Royal Society of London. Series B, Biological sciences 20011229
Title: Systematic structure-based design and stereoselective synthesis of novel multisubstituted cyclopentane derivatives with potent antiinfluenza activity.
Journal: Journal of medicinal chemistry 20011206
Title: Characterization of an influenza A (H3N2) virus resistant to the cyclopentane neuraminidase inhibitor RWJ-270201.
Journal: Antiviral research 20011201
Title: Comparison of the activities of zanamivir, oseltamivir, and RWJ-270201 against clinical isolates of influenza virus and neuraminidase inhibitor-resistant variants.
Journal: Antimicrobial agents and chemotherapy 20011201
Title: Comparison of efficacies of RWJ-270201, zanamivir, and oseltamivir against H5N1, H9N2, and other avian influenza viruses.
Journal: Antimicrobial agents and chemotherapy 20011001
Title: Influence of virus strain, challenge dose, and time of therapy initiation on the in vivo influenza inhibitory effects of RWJ-270201.
Journal: Antiviral research 20010901
Title: Primary immune system effects of the orally administered cyclopentane neuraminidase inhibitor RWJ-270201 in influenza virus-infected mice.
Journal: International immunopharmacology 20010601
Title: Comparison of the anti-influenza virus activity of RWJ-270201 with those of oseltamivir and zanamivir.
Journal: Antimicrobial agents and chemotherapy 20010401
Title: Cyclopentane neuraminidase inhibitors with potent in vitro anti-influenza virus activities.
Journal: Antimicrobial agents and chemotherapy 20010301
Title: In vivo influenza virus-inhibitory effects of the cyclopentane neuraminidase inhibitor RJW-270201.
Journal: Antimicrobial agents and chemotherapy 20010301
Title: BCX-1812 (RWJ-270201): discovery of a novel, highly potent, orally active, and selective influenza neuraminidase inhibitor through structure-based drug design.
Journal: Journal of medicinal chemistry 20000921
Title: Babu YS, et al. BCX-1812 (RWJ-270201): discovery of a novel, highly potent, orally active, and selective influenza neuraminidase inhibitor through structure-based drug design. J Med Chem. 2000 Sep 21;43(19):3482-6.
Title: Young D, et al. RWJ-270201 (BCX-1812): a novel neuraminidase inhibitor for influenza. Philos Trans R Soc Lond B Biol Sci. 2001 Dec 29;356(1416):1905-13.
